申请人:Millennium Pharmaceuticals
公开号:US20040106639A1
公开(公告)日:2004-06-03
The invention provides compounds having the formula:
1
wherein R
1
is halogen. The invention also provides compositions comprising the compounds, and methods of treating diseases or disorders that comprise administering one or more of the compounds to a subject in need thereof. The disclosed compounds have CCR1 antagonist activity.
这项发明提供了具有以下公式的化合物:1其中R1是卤素。该发明还提供了包含这些化合物的组合物,以及治疗疾病或障碍的方法,包括向需要的受试者施用一个或多个这些化合物。所披露的化合物具有CCR1拮抗活性。